PCDHGB7 and cervical carcinoma: The UCOM, PCDHGB7, efficiently distinguishes high-grade squamous intraepithelial lesions (HSILs) and cervical cancer from normal samples and low-grade squamous intraepithelial lesions (LSILs), while most other biomarkers can only differentiate cervical cancer from normal samples30.